Search results
Robert Downey Jr. Says ‘The Sympathizer’ Star Hoa Xuande Pulled ‘All the Same Moves’ as Cillian...
The Wrap via Yahoo News· 4 days ago"All I saw was this guy sacrifice and sacrifice," the HBO star and EP says of his similar costars...
Oppenheimer maintains bullish rating on Broadcom following management meeting By Investing.com
Investing.com· 1 day agoOppenheimer maintains bullish rating on Broadcom following management meeting
Matt Damon's Daughter Isabella's College Plans Revealed
E! News via Yahoo News· 16 hours agoOriginally appeared on E! Online Matt Damon is getting ready to downsize the number of kids at home....
Cartesian Therapeutics (NASDAQ:RNAC) Receives “Outperform” Rating from Oppenheimer
ETF DAILY NEWS· 8 hours agoOppenheimer restated their outperform rating on shares of Cartesian Therapeutics (NASDAQ:RNAC – Free Report) in a report issued on Friday, Benzinga reports. They currently ...
Barnes Group shares target raised by Oppenheimer on valuation outlook By Investing.com
Investing.com· 1 day agoOn Friday, Oppenheimer adjusted its outlook on Barnes Group (NYSE:B) shares, a global provider of...
Oppenheimer & Co. Inc. Increases Stock Position in iShares Russell Top 200 Value ETF (NYSEARCA:IWX)
ETF DAILY NEWS· 6 days agoOppenheimer & Co. Inc. boosted its stake in shares of iShares Russell Top 200 Value ETF (NYSEARCA:IWX – Free Report) by 8.2% in the 4th quarter, according to the company in ...
Oppenheimer Reiterates “Outperform” Rating for Adobe (NASDAQ:ADBE)
ETF DAILY NEWS· 1 day agoAdobe (NASDAQ:ADBE – Get Free Report)‘s stock had its “outperform” rating reiterated by equities research analysts at Oppenheimer in a report released on Friday, Benzinga ...
NVIDIA’s stock price prediction: Can it hit $150? | Invezz
Invezz· 3 days agoOn June 11, 2024, Oppenheimer raised its price target on NVIDIA Corp (NASDAQ:NVDA) stock from $110...
Oppenheimer Lowers Cellectis (NASDAQ:CLLS) Price Target to $10.00
ETF DAILY NEWS· 1 day agoCellectis (NASDAQ:CLLS – Get Free Report) had its target price dropped by Oppenheimer from $11.00 to $10.00 in a note issued to investors on Wednesday, Benzinga reports. The ...
Oppenheimer & Co. Inc. Acquires 607 Shares of The Clorox Company (NYSE:CLX)
ETF DAILY NEWS· 6 days agoOppenheimer & Co. Inc. increased its holdings in The Clorox Company (NYSE:CLX – Free Report) by 4.2% during the 4th quarter, Holdings Channel reports. The firm owned 15,159 ...